XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statement of Changes in Equity (Statement) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit and Cumulative Distributions
Accumulated Deficit and Cumulative Distributions
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interests
Non-controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total Equity, Excluding Redeemable Non Controlling Interest
Total Equity, Excluding Redeemable Non Controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
Class I Common Shares
Common Stock
Class D Common Shares
Common Stock
Class S Common Shares
Common Stock
Beginning balance at Dec. 31, 2022 $ 1,029,650 $ (7,157) $ 736,083 $ (5,162)   $ 744,852 $ 3,678 $ (13,212) $ (5,162) $ 293,567 $ (1,995) $ 1,029,650 $ (7,157) $ 317 $ 14 $ 434
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued     582,932     582,362           582,932   329 21 220
Offering costs     (20,634)     (20,634)           (20,634)        
Distribution reinvestment     15,394     15,380           15,394   6   8
Common stock repurchases     (19,343)   $ (19,343) (19,324)           (19,343)   (9)   (8)
Amortization of restricted stock grants     74     74           74        
Net income 22,918   18,156         18,156   4,698   22,854        
Other comprehensive income 23,174   19,512       19,512     3,586   23,098        
Distributions declared on common shares     (36,954)         (36,954)       (36,954)        
Redeemable common share measurement adjustment     (142)     (142)           (142)        
Contributions from non-controlling interests                   59   59        
Distributions to and redemptions of non-controlling interests                   (31,742)   (31,742)        
Redeemable non-controlling interests measurement adjustment     (5)     (5)           (5)        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership     (3,696)     (3,696)       3,642   (54)        
Ending balance at Jun. 30, 2023 1,558,030   1,286,215     1,298,867 23,190 (37,172)   271,815   1,558,030   643 33 654
Beginning balance at Mar. 31, 2023     1,022,892     1,048,029 (2,067) (24,143)   269,549   1,292,441   495 27 551
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued     271,648     271,383           271,648   153 8 104
Offering costs     (11,041)     (11,041)           (11,041)        
Distribution reinvestment     8,915     8,906           8,915   4   5
Common stock repurchases     (17,201)   $ (17,201) (17,184)           (17,201)   (9) (2) (6)
Amortization of restricted stock grants     37     37           37        
Net income 9,633   7,846         7,846   1,759   9,605        
Other comprehensive income 30,524   25,257       25,257     5,190   30,447        
Distributions declared on common shares     (20,875)         (20,875)       (20,875)        
Redeemable common share measurement adjustment     (145)     (145)           (145)        
Contributions from non-controlling interests                   29   29        
Distributions to and redemptions of non-controlling interests                   (5,824)   (5,824)        
Redeemable non-controlling interests measurement adjustment     10     10           10        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership     (1,128)     (1,128)       1,112   (16)        
Ending balance at Jun. 30, 2023 $ 1,558,030   $ 1,286,215     $ 1,298,867 $ 23,190 $ (37,172)   $ 271,815   $ 1,558,030   $ 643 $ 33 $ 654